Welcome to the e-CCO Library!

P143: Measuring the mediating effects of tofacitinib on health status in ulcerative colitis: data from the OCTAVE programme
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

M. Dubinsky1, A. Bushmakin2, M. DiBonaventura3, J. Cappelleri4, L. Salese5, E. Maller5, A. Armuzzi*6

Created: Friday, 22 February 2019, 9:41 AM
P143: Outcomes of ulcerative colitis-associated dysplasia patients treated with endoscopic submucosal dissection: An extended analysis of a single center cohort
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Park, S.(1)*;Hong, S.W.(1);Hwang, S.W.(1);Park, S.H.(1);Ye, B.D.(1);Byeon, J.S.(1);Myung, S.J.(1);Yang, S.K.(1);Yang, D.H.(1);
Created: Friday, 14 July 2023, 10:48 AM
P143: Quality in inflammatory bowel disease care: measure, educate, and improve—a real-life survey
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

C. Viganò*1, G. Meucci2, S. Saibeni3, C. C. Cortelezzi4, A. Amato5

Created: Friday, 22 February 2019, 9:49 AM
P143: Risk of impaired nutritional status is associated with an unfavourable disease outcome in IBD
Year: 2018
Source: ECCO '18 Vienna
Authors:

C. Spooren1,2*, M. de Jong1,2, A. Masclee1,2, M. Pierik1,2, D. Jonkers1,2

Created: Thursday, 21 February 2019, 9:14 AM
P144 Vitamin C deficiency in inflammatory bowel disease: the forgotten micronutrient
Year: 2020
Source:

ECCO'20 Vienna

Authors:

K. Dunleavy MB BCh BAO1, R. Ungaro2, L. Manning2, J. Novak3, S. Gold2, J.F. Colombel2

Created: Thursday, 30 January 2020, 10:12 AM
P144: Changes of fecal metabolic and lipidomic features by anti-tumor necrosis factor treatment and prediction of clinical remission in patients with ulcerative colitis
Year: 2022
Source: ECCO'22
Authors: ShinShin, S.(1);Kim, S.Y.(2);Park, S.J.(3);Im, J.P.(4);Kim, H.J.(5);Lee, K.M.(6); Kim, J.W.(7); Jung, S.A.(8);Lee, J.(9);Kang, S.B.(10); Shin, S.J.(11);Kim, E.S.(12); Kim, Y.S.(13);Kim, T.O.(14);Kim, H.S.(15);Park, D.I.(16);Kim, H.K.(17); Kim, E.S.(18); Kim, Y.H.(19);Teng, D.(20);Kim, J.H.(21);Kim, W.(21);Saeed, M.(2); Moon, J.M.(1);Kim, K.(1);Choi, C.H.(1);Choi, H.K.(2);
Created: Friday, 11 February 2022, 3:52 PM
P144: Clock gene expression levels inversely correlate with disease activity in ulcerative colitis and Crohn’s disease
Year: 2021
Source: ECCO'21 Virtual
Authors: Weintraub, Y.(1,2);Cohen, S.(1,2);Chapnik, N.(3);Anafy, A.(1,2);Yerushalmy-Feler, A.(1,2);Ben-Tov , A.(1,2);Dotan, I.(2,4);Riva, T.(2,5);Froy, O.(3);
Created: Wednesday, 2 June 2021, 4:12 PM
P144: Comparison between faecal chitinase 3-like 1, matrix metalloprotease 9, and calprotectin to assess mucosal healing in Crohn’s disease: a multicentre prospective study
Year: 2018
Source: ECCO '18 Vienna
Authors:

A. Buisson1,2*, M. Fumery3, X. Hébuterne4, B. Pariente5, S. Nancey6, R. Minet Quinard7, L. Peyrin-Biroulet8, P. Seksik9, M. Allez10, C. Lambert11, J.-L. Dupas12, J. Filippi4, M. Nachury13, G. Boschetti6, M. Goutte1,2, B. Pereira11, D. Bouvier7, G. Bommelaer1,2, N. Barnich2, E. Vazeille1,2

Created: Thursday, 21 February 2019, 9:14 AM
P144: Correlation between clinical, endoscopic, histological activity scores in a cohort of patients with ulcerative colitis: a prospective study
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

B. Neri*1, S. Romeo1, F. Zorzi1, E. De Cristofaro1, E. Calabrese1, E. Grasso1, G. Palmieri2, L. Biancone1

Created: Friday, 22 February 2019, 9:41 AM
P144: Impact of major medication discontinuation during the first wave of COVID-19 pandemic on the risk of early relapse in patients with inflammatory bowel disease: a French observational retrospective study
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Meunier, C.(1)*;Monte, C.(1);Hadjisavvas, H.(1);Rozieres, A.(2);Roblin, X.(3);Venturin, C.(1);Gay, C.(1);Flourie, B.(1);Boschetti, G.(1);Danion, P.(1);Mathieu, N.(4);Charlois, A.L.(5);Faure, M.(6);Nancey, S.(7);
Created: Friday, 14 July 2023, 10:48 AM
P144: Protozoa and bacterial infections are relevant for clinical outcomes in ulcerative colitis: a study from Latin American country
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Gutierrez-Grobe Y., Barrera-Ochoa C., Yamamoto-Furusho J.

Created: Wednesday, 20 February 2019, 10:36 AM
P144: TNF-inhibitor use and efficacy in upper-GI Crohn’s disease: results from a multicentre retrospective study
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

W. Bos*1, E. H. Lamers1, B. Oldenburg1, A. E. van der Meulen - de Jong2, G. Dijkstra3, 4, M. Pierik5, Q. van der Vliet1, A. M. van der Aalst5, K. van der Aalst1, J. J. ten Thije1, M. van der Have1, H. H. Fidder1

Created: Friday, 22 February 2019, 9:49 AM
P145 Orofacial granulomatosis in Crohn’s disease: an ECCO CONFER multi-centre case series
Year: 2020
Source:

ECCO'20 Vienna

Authors:

F. Phillips1, B. Verstockt2,3, M. Sladek4, N. de Boer5, K. Katsanos6, K. Karmiris7, A. Albshesh8,9, C. Eriksson10, D. Bergemalm10, T. Molner11, P. Ellul12, ECCO CONFER Investigators

Created: Thursday, 30 January 2020, 10:12 AM
P145: Exploring mucosal function as a clinical endpoint in ulcerative colitis
Year: 2018
Source: ECCO '18 Vienna
Authors:

S. Kjaergaard1*, M.M.B. Damm1, J. Chang2, L.B. Riis3, R. Hytting-Andreasen4, S.M. Krug5, J.D. Schulzke5, N. Bindslev6, M.B. Hansen1

Created: Thursday, 21 February 2019, 9:14 AM
P145: Inflammatory Bowel Disease patients requiring surgery can be treated in referral centres regardless of the COVID-19 status of the hospital: results of a multicentric European study during the first COVID-19 outbreak (COVIBD-Surg)
Year: 2021
Source: ECCO'21 Virtual
Authors: Rottoli, M.(1);Pellino, G.(2);Tanzanu, M.(1);Baldi, C.(3);Frontali, A.(4);Carvello, M.(5);Foppa, C.(5);Kontovounisios, C.(6);Tekkis, P.(6);Colombo, F.(7);Sancho-Muriel, J.(8);Matteo, F.(8);Danelli, P.(7);Celentano, V.(6);Spinelli, A.(5);Panis, Y.(4);Sampietro, G.(3);Poggioli, G.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P145: Measuring access and quality of care indicators in inflammatory bowel disease in a tertiary referral center
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Golovics P.A., Gonczi L., Kurti Z., Lovasz B.D., Gecse K.B., Vegh Z., Lakatos P.L.

Created: Wednesday, 20 February 2019, 10:36 AM
P145: Migraine is the most frequent extra-intestinal manifestation in patients with inflammatory bowel disease
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

X. Moisset1, 2, G. Bommelaer3, 4, M. Boube3, L. Ouchchane5, M. Goutte3, 4, M. Dapoigny3, R. Dallel2, A. Guttman5, P. Clavelou1, A. Buisson*3, 4

Created: Friday, 22 February 2019, 9:49 AM
P145: Phenotypic progression of Crohn's disease : assessment of risk factors in a Tunisian population
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Ben Safta, N.(1)*;Ben Mustpha, N.(1);Khemiri, W.(1);Serghini, M.(1);Laabidi, S.(1);Fekih, M.(1);Labidi, A.(1);Boubaker, J.(1);
Created: Friday, 14 July 2023, 10:48 AM
P145: Telephone straight-to-test (tSTT) improves early diagnosis of inflammatory bowel disease (IBD)
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

H. Htet*1, T. Mudege1, S. Hoque1

Created: Friday, 22 February 2019, 9:41 AM
P145: Ultrasonographic parameters associated with mucosal healing 1 year after infliximab therapy in Crohn’s Disease: a multicentric and prospective study
Year: 2022
Source: ECCO'22
Authors: Nascimento, C.(1);Frias Gomes, C.(1);Morão, B.(1);Cúrdia Gonçalves, T.(2);Dias de Castro, F.(2);Moreira, M.J.(2);Cotter, J.(2);Pereira, F.(3);Caldeira, A.(3);Rosa, C.(4);Macedo, G.(4);Macedo, C.(5);Ferreira, M.(5);Cravo, M.(1);Glória, L.(1);Torres, J.(1);Palmela, C.(1);
Created: Friday, 11 February 2022, 3:52 PM